BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.94 EUR | +1.11% |
|
+2.94% | -19.91% |
| Jul. 12 | European Midday Briefing : Stocks Extend Rally as U.S. Rate Cut Hopes Deepen | DJ |
| Jul. 12 | BAYER AG : Jefferies gives a Neutral rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
26.94
EUR
Average target price
36.14
EUR
Spread / Average Target
+34.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.91% | 28.86B | |
| +62.66% | 854B | |
| +40.42% | 636B | |
| -4.37% | 361B | |
| +17.16% | 324B | |
| +9.87% | 301B | |
| +15.66% | 247B | |
| +4.21% | 230B | |
| +17.90% | 228B | |
| +14.86% | 177B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer Appoints Former Roche Executive as CEO
